DE602004009068D1 - Glycosaminoglykane zur behandlung emotionaler störungen - Google Patents

Glycosaminoglykane zur behandlung emotionaler störungen

Info

Publication number
DE602004009068D1
DE602004009068D1 DE602004009068T DE602004009068T DE602004009068D1 DE 602004009068 D1 DE602004009068 D1 DE 602004009068D1 DE 602004009068 T DE602004009068 T DE 602004009068T DE 602004009068 T DE602004009068 T DE 602004009068T DE 602004009068 D1 DE602004009068 D1 DE 602004009068D1
Authority
DE
Germany
Prior art keywords
treatment
glycosaminoglycane
emotional disorder
anxiety
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004009068T
Other languages
English (en)
Other versions
DE602004009068T2 (de
Inventor
Umberto Cornelli
Ambrosi Luigi De
Stanley Lorens
Jawed Fareed
John Lee
Israel Hanin
Ronald Mervis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602004009068D1 publication Critical patent/DE602004009068D1/de
Application granted granted Critical
Publication of DE602004009068T2 publication Critical patent/DE602004009068T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
DE602004009068T 2003-05-21 2004-05-19 Glycosaminoglykane zur behandlung emotionaler störungen Expired - Fee Related DE602004009068T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20030102 2003-05-21
IT001023A ITMI20031023A1 (it) 2003-05-21 2003-05-21 Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
PCT/EP2004/050860 WO2004103381A1 (en) 2003-05-21 2004-05-19 Glycosaminoglycans for treatment emotional dysfunctions

Publications (2)

Publication Number Publication Date
DE602004009068D1 true DE602004009068D1 (de) 2007-10-31
DE602004009068T2 DE602004009068T2 (de) 2008-06-19

Family

ID=30131059

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009068T Expired - Fee Related DE602004009068T2 (de) 2003-05-21 2004-05-19 Glycosaminoglykane zur behandlung emotionaler störungen

Country Status (21)

Country Link
US (1) US7812005B2 (de)
EP (1) EP1631298B8 (de)
JP (1) JP4757197B2 (de)
KR (1) KR20060025142A (de)
CN (1) CN100377717C (de)
AT (1) ATE373480T1 (de)
AU (1) AU2004241748B2 (de)
CA (1) CA2526201A1 (de)
DE (1) DE602004009068T2 (de)
DK (1) DK1631298T3 (de)
ES (1) ES2294507T3 (de)
HK (1) HK1084023A1 (de)
IL (1) IL171981A (de)
IT (1) ITMI20031023A1 (de)
NO (1) NO20056089L (de)
NZ (1) NZ544238A (de)
PL (1) PL1631298T3 (de)
PT (1) PT1631298E (de)
RU (1) RU2353371C2 (de)
WO (1) WO2004103381A1 (de)
ZA (1) ZA200510132B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
CN107760713B (zh) * 2016-08-23 2020-05-05 中国科学院上海药物研究所 一种非人哺乳动物神经精神疾病动物模型的建立方法及其用途
CN112438991B (zh) * 2019-08-29 2024-03-15 鲁南制药集团股份有限公司 肝素、或其衍生物、或其可药用盐的医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
IT1205042B (it) 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2763848B1 (fr) * 1997-05-28 2000-01-28 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
FR2763849B1 (fr) * 1997-05-28 2000-09-15 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
JP4412756B2 (ja) * 1998-02-26 2010-02-10 生化学工業株式会社 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile

Also Published As

Publication number Publication date
AU2004241748A1 (en) 2004-12-02
KR20060025142A (ko) 2006-03-20
DE602004009068T2 (de) 2008-06-19
IL171981A (en) 2010-04-15
RU2353371C2 (ru) 2009-04-27
WO2004103381A1 (en) 2004-12-02
CN100377717C (zh) 2008-04-02
DK1631298T3 (da) 2008-01-28
IL171981A0 (en) 2006-04-10
ATE373480T1 (de) 2007-10-15
PT1631298E (pt) 2007-12-31
CA2526201A1 (en) 2004-12-02
ZA200510132B (en) 2006-08-30
ES2294507T3 (es) 2008-04-01
EP1631298B8 (de) 2008-12-24
AU2004241748B2 (en) 2010-05-13
ITMI20031023A1 (it) 2004-11-22
JP2006528670A (ja) 2006-12-21
EP1631298A1 (de) 2006-03-08
JP4757197B2 (ja) 2011-08-24
EP1631298B1 (de) 2007-09-19
RU2005138517A (ru) 2006-08-27
PL1631298T3 (pl) 2008-04-30
NZ544238A (en) 2008-08-29
ITMI20031023A0 (it) 2003-05-21
HK1084023A1 (en) 2006-07-21
NO20056089L (no) 2006-02-09
US7812005B2 (en) 2010-10-12
CN1791416A (zh) 2006-06-21
US20060205690A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
JO2686B1 (en) Vehicles
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
PT2332940E (pt) Azaindoles úteis como inibidores de jak e outras proteínas quinases
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
TW200510416A (en) P38 inhibitors and methods of use thereof
SE0301700D0 (sv) Novel compounds
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
MY147677A (en) Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
SE0302139D0 (sv) Novel compounds
EA200801302A1 (ru) Композиции и способы лечения нарушений цнс
TW200505865A (en) Compounds useful for the treatment of diseases
ATE459353T1 (de) Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee